Oculis Holding AG
OCS • NASDAQ
Oculis Holding AG is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Riad Sherif, with a market cap of $1.4B.
CEORiad Sherif
Next Earnings
Upcoming earnings announcement for Oculis Holding AG
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.49
Revenue Estimate
$320.0K
Earnings History
Past 9 earnings reports for Oculis Holding AG
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Q4 2025 | -$0.53Est: -$0.43 | -23.3% | $514.2KEst: $270.0K | +90.4% | — |
| Nov 10, 2025 | Q3 2025 | -$0.40Est: -$0.50 | +20.0% | $303.8KEst: $250.0K | +21.5% | — |
| Aug 21, 2025 | Q2 2025 | -$0.57Est: -$0.53 | -7.5% | $307.4KEst: $250.0K | +23.0% | — |
| May 8, 2025 | Q1 2025 | -$0.77Est: -$0.40 | -92.5% | $316.8KEst: $217.5K | +45.6% | — |
| Mar 11, 2025 | Q4 2024 | -$0.76Est: -$0.38 | -100.0% | $3.4KEst: $243.4K | -98.6% | — |
| Nov 7, 2024 | Q3 2024 | -$0.55Est: -$0.57 | +3.5% | $249.5KEst: $290.0K | -14.0% | — |
| Aug 27, 2024 | Q2 2024 | -$0.56Est: -$0.47 | -19.1% | $270.9KEst: $300.0K | -9.7% | — |
| May 8, 2024 | Q1 2024 | -$0.50Est: -$0.41 | -22.0% | $254.1KEst: $280.0K | -9.3% | — |
| Mar 18, 2024 | Q4 2023 | -$0.38 | — | $208.6K | — | — |